Fury, M. G., Baxi, S., Shen, R., Kelly, K. W., Lipson, B. L., Carlson, D., . . . Pfister, D. G. (2011). Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Citação norma ChicagoFury, Matthew G., Shrujal Baxi, Ronglai Shen, Katherine W. Kelly, Brynna L. Lipson, Diane Carlson, Hilda Stambuk, Sofia Haque, and David G. Pfister. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.
Citação norma MLAFury, Matthew G., et al. Phase II Study of Saracatinib (AZD0530) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.